Piramal Life Sciences Q3 FY11 Results : Net loss narrows down

by khalid on 17/02/2011 · 0 comments

Piramal Life Sciences Limited has posted a net loss for the period Q3 (ending Dec 10) of the current fiscal (FY10-11) but this loss has narrowed down. During the said quarter, net loss got down to Rs 25.68 crores in comparison to Rs 36.76 crores of Q3 (ending Dec 09) of previous year (FY09-10). Piramal Life Sciences Limited is an independent research driven drug company that was recently demerged from Piramal Healthcare Limited. The company has state-of-the-art R&D laboratories built over 200,000 square-feet of space in Mumbai and over 300 scientists engaged in drug discovery and development.

The company has informed the share market (BSE/NSE) that the net sales rose 11.46 times to Rs 13.98 crore in Q3 (ending Dec 2010) of the current fiscal (FY10-11) when compared with the same quarter Q3 (ending Dec 2009) of previous year (FY09-10). Total income was Rs 1.22 crores in last year’s quarter Q3.

Share’s Data :-
BSE Code : 532979
Mkt. Cap : Rs 228.74 Crores
Piramal Life Sciences Ltd. share’s CMP is Rs 89.70 on 16th Feb 2011.

Stay tuned to BelltheBull Blog for more news on Piramal Life Sciences Limited !

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: